SCHEMBL16225035

SCHEMBL16225035

CCO[Si](CCCN(CCCN(C)C)CCCN(C)C)(OCC)OCC

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 3/20 0.33
ALDH1A1 P00352 3/20 0.33
TSHR P16473 1/20 0.33
KDM4E B2RXH2 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16813095 0.92 DNM1 (0.33) DNM1ALDH1A1TSHRKDM4ESMN1; SMN2
SCHEMBL22289262 0.92
SCHEMBL329406 0.92 ALDH1A1 (0.39) DNM1ALDH1A1TSHRKDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL20741376 0.90 DNM1 (0.41) DNM1ALDH1A1TSHRKDM4ESMN1; SMN2
SCHEMBL555040 0.89
SCHEMBL30952078 0.87
SCHEMBL16813174 0.86
SCHEMBL16813802 0.86 SLC2A1 (0.35)
SCHEMBL379968 0.85 ALDH1A1 (0.43) DNM1ALDH1A1TSHRKDM4ESMN1; SMN2
SCHEMBL16813271 0.85 KDM5A (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9062182-B2 Terminal modifier for conjugated diene polymers KOREA KUMBO PETROCHEMICAL CO., LTD. (KR) 2015-06-23 US claimed
US-9062182-B2 Terminal modifier for conjugated diene polymers KOREA KUMBO PETROCHEMICAL CO., LTD. (KR) 2015-06-23 US disclosed
US-20140335167-A1 Consumer Products Comprising Silane-Modified Oils THE PROCTER & GAMBLE COMPANY (US) 2014-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140335167-A1 Consumer Products Comprising Silane-Modified Oils SGMS2, SGMS1, SCD DNM1 4697/4885ALDH1A1 1386/4885TSHR 3112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.